{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:05:55Z","timestamp":1790996755468,"version":"4.1.0"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:p>Patients with ocular infections are at increased risk of vision impairment and may require immediate medical care to preserve their vision. Management of ocular bacterial infections has evolved in recent years and includes a pragmatic selection of broad-spectrum antibiotics based on the causative bacteria. Nevertheless, the treatment of bacterial ocular infections is increasingly becoming a challenge, as the causative bacterium acquires resistance to antibiotics through intrinsic and acquired methods. From an Indian perspective, along with the challenges of antibiotic resistance, there are other factors such as lack of knowledge on epidemiology, and lack of data on local susceptibility patterns of ocular pathogens that have significant impact on the management of ocular infections. This narrative review summarizes the available knowledge on prescribing antibiotics for five common ocular infections in India. It further highlights the significance of the understanding of antimicrobial susceptibility patterns across India as a cornerstone to promote rational use of ocular antibiotics. This review indicates that large-scale antimicrobial resistance surveillance studies can facilitate the synchronization of ophthalmic antimicrobial prescription policies with local antibiotic resistance patterns. Further, establishment of an antimicrobial stewardship program in ophthalmology can potentially increase the efficacy of diagnostic tools, and implement earlier adoption of effective antibiotics. Overall, this review provides consolidated information and key considerations for treatment decision-making of common ocular infections in India.<\/jats:p>","DOI":"10.4103\/ijo.ijo_2537_21","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T06:53:23Z","timestamp":1652252003000},"page":"1513-1521","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":24,"title":["Emerging antimicrobial resistance and need for antimicrobial stewardship for ocular infections in India: A narrative review"],"prefix":"10.4103","volume":"70","author":[{"given":"Partha","family":"Biswas","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, B B Eye Foundation, Kolkata, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha","family":"Batra","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, B B Eye Foundation, Kolkata, West Bengal, India"},{"name":"Department of Ophthalmology, Trenetralaya Eye Care and Surgical Centre, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Gurha","sequence":"additional","affiliation":[{"name":"Department of Medical Affairs, Novartis Healthcare Private Limited, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Maksane","sequence":"additional","affiliation":[{"name":"Department of Medical Affairs, Novartis Healthcare Private Limited, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"R1-20251006","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2165\/00003495-199652040-00006","article-title":"Common ocular infections A prescriber's guide","volume":"52","author":"Donahue","year":"1996","journal-title":"Drugs"},{"key":"R2-20251006","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3129\/i08-016","article-title":"Blepharitis: Current strategies for diagnosis and management","volume":"43","author":"Jackson","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"R3-20251006","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/OPTH.S6461","article-title":"Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives","volume":"4","author":"Kernt","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"R4-20251006","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1167\/iovs.18-23783","article-title":"Epidemiology and mortality-related prognostic factors in endophthalmitis","volume":"59","author":"Weng","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R5-20251006","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.pop.2015.05.001","article-title":"Conjunctivitis","volume":"42","author":"Alfonso","year":"2015","journal-title":"Prim Care"},{"key":"R6-20251006","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12886-017-0612-2","article-title":"Bacterial profile of ocular infections: A systematic review","volume":"17","author":"Teweldemedhin","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"R7-20251006","first-page":"579","article-title":"Antibiotic therapy for ocular infection","volume":"161","author":"Snyder","year":"1994","journal-title":"West J Med"},{"key":"R8-20251006","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2147\/OPTH.S5778","article-title":"Impact of antibiotic resistance in the management of ocular infections: The role of current and future antibiotics","volume":"3","author":"Bertino","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"R9-20251006","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4103\/0255-0857.83903","article-title":"Antibiotic resistance in ocular bacterial pathogens","volume":"29","author":"Sharma","year":"2011","journal-title":"Indian J Med Microbiol"},{"key":"R10-20251006","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archophthalmol.2011.45","article-title":"Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures","volume":"129","author":"Fintelmann","year":"2011","journal-title":"Arch Ophthalmol (Chicago, Ill: |y1960)"},{"key":"R11-20251006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40135-013-0022-4","article-title":"Update on antimicrobial resistance and ocular isolates","volume":"1","author":"Garg","year":"2013","journal-title":"Curr Ophthalmol Rep"},{"key":"R12-20251006","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.ajo.2008.01.025","article-title":"Ocular TRUST: Nationwide antimicrobial susceptibility patterns in ocular isolates","volume":"145","author":"Asbell","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R14-20251006","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1590\/S0004-27492013000600006","article-title":"Prevalence and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus in ocular infections","volume":"76","author":"Vola","year":"2013","journal-title":"Arq Bras Oftalmol"},{"key":"R15-20251006","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13054-017-1801-3","article-title":"Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment","volume":"21","author":"Hassoun","year":"2017","journal-title":"Crit Care"},{"key":"R18-20251006","doi-asserted-by":"crossref","first-page":"108476","DOI":"10.1016\/j.exer.2021.108476","article-title":"Microbes of the human eye: Microbiome, antimicrobial resistance and biofilm formation","volume":"205","author":"Ranjith","year":"2021","journal-title":"Exp Eye Res"},{"key":"R19-20251006","doi-asserted-by":"crossref","first-page":"184","DOI":"10.18295\/2075-0528.2789","article-title":"Bacterial keratitis: Perspective on epidemiology, clinico-pathogenesis, diagnosis and treatment","volume":"9","author":"Al-Mujaini","year":"2009","journal-title":"Sultan Qaboos Univ Med J"},{"key":"R20-20251006","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4103\/0255-0857.62481","article-title":"Ocular infections: Research in India","volume":"28","author":"Sharma","year":"2010","journal-title":"India J Med Microbiol"},{"key":"R21-20251006","first-page":"72","article-title":"Pharmacoepidemiological observational study of antimicrobial use in outpatients of ophthalmology department in North Indian population","author":"Hina","year":"2018","journal-title":"J Pharm Bioallied Sci"},{"key":"R22-20251006","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4103\/2141-9248.139372","article-title":"Drug utilization study in ophthalmology out-patient department of a Medical College in India","volume":"4","author":"Banerjee","year":"2014","journal-title":"Ann Med Health Sci Res"},{"key":"R23-20251006","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.meegid.2019.01.031","article-title":"A ten year study of prevalence, antimicrobial susceptibility pattern, and genotypic characterization of Methicillin resistant Staphylococcus aureus causing ocular infections in a tertiary eye care hospital in South India","volume":"69","author":"Nithya","year":"2019","journal-title":"Infect Genet Evol"},{"key":"R24-20251006","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/bjo.2004.059519","article-title":"Variability in the content of Indian generic ciprofloxacin eye drops","volume":"89","author":"Weir","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R25-20251006","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S1473-3099(10)70246-2","article-title":"Generic antibiotics, antibiotic resistance, and drug licensing","volume":"10","author":"Finch","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R26-20251006","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/CMR.00072-14","article-title":"Substandard\/counterfeit antimicrobial drugs","volume":"28","author":"Kelesidis","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"R28-20251006","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4065\/mcp.2011.0358","article-title":"Antimicrobial stewardship","volume":"86","author":"Doron","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"R30-20251006","doi-asserted-by":"crossref","first-page":"67","DOI":"10.18773\/austprescr.2018.016","article-title":"Common eye infections","volume":"41","author":"Watson","year":"2018","journal-title":"Aust Prescr"},{"key":"R31-20251006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/pho.2014.3819","article-title":"Intense pulsed light treatment for dry eye disease due to meibomian gland dysfunction;a 3-year retrospective study","volume":"33","author":"Toyos","year":"2015","journal-title":"Photomed Laser Surg"},{"key":"R33-20251006","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s11908-012-0238-8","article-title":"Dacryocystitis: Systematic approach to diagnosis and therapy","volume":"14","author":"Pinar-Sueiro","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"R36-20251006","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/ICU.0000000000000274","article-title":"Surgical management of corneal infections","volume":"27","author":"Tuli","year":"2016","journal-title":"Curr Opin Ophthalmol"},{"key":"R39-20251006","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jtos.2014.05.005","article-title":"Treatment of blepharitis: Recent clinical trials","volume":"12","author":"Pflugfelder","year":"2014","journal-title":"Ocular Surface"},{"key":"R40-20251006","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/ICU.0000000000000164","article-title":"Medical management of blepharitis","volume":"26","author":"Duncan","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"R43-20251006","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ophtha.2018.10.020","article-title":"Conjunctivitis preferred practice pattern\u00ae","volume":"126","author":"Varu","year":"2019","journal-title":"Ophthalmology"},{"key":"R44-20251006","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/ijo.IJO_870_16","article-title":"Chlamydial eye infections: Current perspectives","volume":"65","author":"Satpathy","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"R46-20251006","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2147\/OPTH.S100280","article-title":"Microbiology of primary acquired nasolacrimal duct obstruction: Simple epiphora, acute dacryocystitis, and chronic dacryocystitis","volume":"10","author":"Pornpanich","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"R47-20251006","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/08820538.2019.1578382","article-title":"High prevalence of Biofilm-forming MRSA in the conjunctival flora in chronic dacryocystitis","volume":"34","author":"Mitra","year":"2019","journal-title":"Semin Ophthalmol"},{"key":"R48-20251006","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3109\/08820538.2013.833269","article-title":"Clinical profile and management outcome of acute dacryocystitis: Two decades of experience in a tertiary eye care center","volume":"30","author":"Ali","year":"2015","journal-title":"Semin Ophthalmol"},{"key":"R49-20251006","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4103\/0970-0218.120153","article-title":"Burden of corneal blindness in India","volume":"38","author":"Gupta","year":"2013","journal-title":"Indian J Community Med"},{"key":"R50-20251006","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/JOCO.JOCO_113_20","article-title":"Delhi infectious keratitis study: Update on clinico-microbiological profile and outcomes of infectious keratitis","volume":"32","author":"Acharya","year":"2020","journal-title":"J Curr Ophthalmol"},{"key":"R51-20251006","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/bjophthalmol-2014-305000","article-title":"Trends in bacterial and fungal keratitis in South India, 2002-2012","volume":"99","author":"Lalitha","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R52-20251006","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/jcor.jcor_16_18","article-title":"Incidence of various causes of infectious keratitis in the part of rural central India and its visual morbidity: Prospective hospital-based observational study","volume":"7","author":"Mohod","year":"2019","journal-title":"J Clin Ophthalmol Res"},{"key":"R54-20251006","doi-asserted-by":"crossref","DOI":"10.4103\/njo.njo_2_18","article-title":"Microbial keratitis\u2014A review of epidemiology, pathogenesis, ocular manifestations, and management","volume":"26","author":"Ezisi","year":"2018","journal-title":"Niger J Ophthalmol"},{"key":"R55-20251006","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jcjo.2012.09.001","article-title":"Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: Systematic review and meta-analysis of comparative studies","volume":"47","author":"Hanet","year":"2012","journal-title":"Can J Ophthalmol"},{"key":"R56-20251006","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4274\/tjo.galenos.2020.37346","article-title":"The value of fortified aminoglycoside\/cephalosporin treatment as first-line treatment and in fluoroquinolone-resistant bacterial keratitis","volume":"50","author":"Dikmeta\u015f","year":"2020","journal-title":"Turk J Ophthalmol"},{"key":"R57-20251006","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/bjophthalmol-2016-308487","article-title":"Trends in antibiotic resistance in bacterial keratitis isolates from South India","volume":"101","author":"Lalitha","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"R58-20251006","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3341\/kjo.2017.0036","article-title":"Endophthalmitis","volume":"31","author":"Sheu","year":"2017","journal-title":"Korean J Ophthalmol"},{"key":"R59-20251006","first-page":"673","article-title":"A literature review and update on the incidence and microbiology spectrum of postcataract surgery endophthalmitis over past two decades in India","volume":"65","author":"Lalitha","year":"2017"},{"key":"R61-20251006","first-page":"214","article-title":"Clinicomicrobiological profile of endophthalmitis: A 10 year experience in a tertiary care center in North India","volume":"60","author":"Satpathy","year":"2017"},{"key":"R62-20251006","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/IAE.0000000000001603","article-title":"Emerging worldwide antimicrobial resistance, antibiotic stewardship and alternative intravitreal agents for the treatment of endophthalmitis","volume":"37","author":"Relhan","year":"2017","journal-title":"Retina (Philadelphia, Pa)"},{"key":"R63-20251006","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4103\/ijo.IJO_1145_19","article-title":"Antibiotic sensitivity trends of pseudomonas endophthalmitis in a tertiary eye care center in South India: A 12-year retrospective study","volume":"68","author":"Pan","year":"2020","journal-title":"India J Opthamology"},{"key":"R64-20251006","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/IAE.0000000000000469","article-title":"Endophthalmitis caused by pseudomonas aeruginosa: Clinical features, antibiotic susceptibilities, and treatment outcomes","volume":"35","author":"Sridhar","year":"2015","journal-title":"Retina (Philadelphia, Pa)"},{"key":"R67-20251006","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/S1473-3099(14)70780-7","article-title":"Global antibiotic consumption 2000 to 2010: An analysis of national pharmaceutical sales data","volume":"14","author":"Van Boeckel","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"R69-20251006","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/ICO.0000000000000431","article-title":"Antibiotic resistance in the treatment of staphylococcus aureus keratitis: A 20-year review","volume":"34","author":"Chang","year":"2015","journal-title":"Cornea"},{"key":"R70-20251006","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/0975-7406.76481","article-title":"Generic antibiotic industries: Challenges and implied strategies with regulatory perspectives","volume":"3","author":"Venkatesh","year":"2011","journal-title":"J Pharm Bioallied Sci"},{"key":"R71-20251006","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.4103\/jfmpc.jfmpc_436_19","article-title":"An analysis of the use of antimicrobial agents in outdoor patients of ophthalmology","volume":"8","author":"Patel","year":"2019","journal-title":"J Family Med Prim Care"},{"key":"R73-20251006","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3126\/nepjoph.v10i2.23014","article-title":"Assessment of antimicrobial prescribing pattern in the outpatient department of ophthalmology in a tertiary care hospital of Western Uttar Pradesh, India","volume":"10","author":"Jain","year":"2018","journal-title":"Nepal J Ophthalmol"},{"key":"R74-20251006","doi-asserted-by":"crossref","first-page":"163","DOI":"10.7869\/djo.162","article-title":"A review of antibiotic prophylaxis for post-operative endophthalmitis","volume":"26","author":"Goray","year":"2016","journal-title":"Delhi J Ophthalmol"},{"key":"R76-20251006","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jcrs.2008.01.016","article-title":"Increasing prevalence of methicillin resistance in serious ocular infections caused by staphylococcus aureus in the United States: 2000 to 2005","volume":"34","author":"Asbell","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"R77-20251006","doi-asserted-by":"crossref","first-page":"497","DOI":"10.4103\/0301-4738.71678","article-title":"Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India","volume":"58","author":"Bharathi","year":"2010","journal-title":"India J Opthamol"},{"key":"R78-20251006","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/bjo.2010.179747","article-title":"Decreased susceptibility to quinolones in methicillin-resistant staphylococcus aureus isolated from ocular infections at a tertiary eye care centre","volume":"94","author":"Bagga","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R79-20251006","first-page":"403","article-title":"The search for good antimicrobial stewardship","volume":"27","author":"Gerding","year":"2001","journal-title":"Jt Comm J Qual Improv"},{"key":"R81-20251006","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1093\/jac\/dkx164","article-title":"Developing a local antimicrobial resistance action plan: The Cornwall one health antimicrobial resistance group","volume":"72","author":"Powell","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"R83-20251006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13756-020-00751-4","article-title":"The impact of antimicrobial stewardship program implementation at four tertiary private hospitals: Results of a five-years pre-post analysis","volume":"9","author":"Al-Omari","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"key":"R84-20251006","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10096-018-3408-2","article-title":"Meropenem antimicrobial stewardship program: Clinical, economic, and antibiotic resistance impact","volume":"38","author":"Garc\u00eda-Rodr\u00edguez","year":"2019","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R85-20251006","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jac\/dkx492","article-title":"Impact of antibiotic stewardship programmes in Asia: A systematic review and meta-analysis","volume":"73","author":"Lee","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"R86-20251006","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4103\/ijo.IJO_1336_17","article-title":"All India Ophthalmological Society members survey results: Cataract surgery antibiotic prophylaxis current practice pattern 2017","volume":"66","author":"Maharana","year":"2018","journal-title":"India J Opthamol"},{"key":"R87-20251006","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4137\/OED.S4866","article-title":"A European perspective on topical ophthalmic antibiotics: Current and evolving options","volume":"3","author":"Bremond-Gignac","year":"2011","journal-title":"Ophthalmol Eye Dis"},{"key":"R90-20251006","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/1120672117747043","article-title":"Choosing wisely and the use of antibiotics in ophthalmic surgery: There is more than meets the eye","volume":"28","author":"Grosso","year":"2018","journal-title":"Eur J Ophthalmol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2537_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:57:26Z","timestamp":1786647446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_2537_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2537_21","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"2021-09-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}